News

9 Feb 2023 Ibex’s Galen™ Prostate becomes first standalone AI-powered cancer diagnostics solution to obtain CE mark under the IVDR

Read more

24 Jan 2023 Ibex Medical Analytics Enters Collaboration with AstraZeneca and Daiichi Sankyo to Develop AI-based HER2 Scoring Product

Read more
Excellent Outcomes of Ibex’s AI Solution for Breast Cancer Detection

21 Dec 2022 Institut Curie study published in a Nature Journal reporting excellent outcomes of Ibex’s AI solution for breast cancer detection

Read more

14 Dec 2022 Ibex deploys AI-powered cancer diagnostics solution at UPMC

Read more

7 Dec 2022 Leading UK diagnostics provider source LDPath expands AI capabilities with Ibex Medical Analytics

Read more

4 Sep 2022 Ibex announces Galen™ 3.0, a transformative cancer diagnostics platform offering new detection capabilities and a broad feature set

Read more

2 Sep 2022 Ibex and Medipath sign multi-year, multi-site and multi-tissue expansion of AI for cancer diagnosis across France

Read more

1 Sep 2022 Excellent outcomes for Galen Breast

Read more

15 Jun 2022 Ibex obtains CE mark for Galen Gastric, the world’s first AI-powered solution for gastric cancer detection

Read more

21 Mar 2022 Hartford HealthCare and Ibex launch research initiative on AI-powered solution to improve breast cancer diagnosis

Read more

10 Mar 2022 Dedalus and Ibex announce a strategic partnership to bring the power of artificial intelligence to digital pathology

Read more

24 Nov 2021 Ibex selected by India’s Dr. Lal PathLabs to Deliver AI-powered Cancer Diagnostics

Read more